Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Sex-Specific Health and Economic Benefits in Older Women at Risk of Atrial Fibrillation: A Proof-of-Concept Evaluation of an AI-Enabled Strategy for Early Thromboembolic Risk Detection
0
Zitationen
7
Autoren
2026
Jahr
Abstract
Background: Women with atrial fibrillation experience a higher lifetime risk of ischemic stroke, greater stroke severity, and worse functional outcomes than men. Preventive strategies focused on AF detection may therefore miss critical opportunities for early intervention in women. Methods: We developed a decision-analytic Markov model using real-world primary care data from Catalonia (Spain) to evaluate an artificial intelligence (AI) enabled strategy for upstream thromboembolic risk detection. The intervention combined electronic health record–based risk prediction, targeted digital rhythm screening, and individualized anticoagulation. Lifetime clinical and economic outcomes were estimated for adults aged ≥65 years, with pre-specified sex-stratified analysis. Results: Compared with usual care, the AI-enabled strategy reduced ischemic stroke, major adverse cardiovascular events, and long-term disability. Absolute reductions in stroke and disability were greater in women, reflecting higher baseline thromboembolic risk. Per 1000 high-risk women, the strategy prevented more strokes and generated larger quality-adjusted life-year gains than in men. From both healthcare payer and societal perspectives, the intervention was cost-saving in women, driven by reductions in stroke-related disability and long-term care. Conclusions: AI-enabled upstream thromboembolic risk detection may deliver particularly important benefits for older women and represents a promising approach to reduce sex-based inequities in stroke prevention.
Ähnliche Arbeiten
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 · 11.554 Zit.
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
2009 · 11.147 Zit.
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
2020 · 9.786 Zit.
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
2017 · 9.663 Zit.
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
2011 · 9.344 Zit.